Development of an Adherence to Anticoagulant Therapy Scale: A Validity and Reliability Study

Abstract

Purpose: Anticoagulants are an important group of drugs used by many patients with different diseases. There are general adherence scales that measure adherence to treatment in the literature. However, the correct use of the drug alone is not sufficient for adherence with warfarin therapy. To develop Anticoagulant Therapy Adherence Scale for use in patients on warfarin and to examine psycholinguistic and psychometric properties. Methods: The research was of a methodological and consisted of 170 patients. The validity of the scale was tested by using content validity, explanatory and confirmatory factor analysis. The reliability of the scale was examined by utilizing item-total scale correlations and Cronbach’s alpha. Results: After the scale items were created, opinions were received from twenty experts and content validity indexes were found to be above 0.80. In the explanatory factor analysis, a 3-factor structure with factor loads between 0.30 and 0.81 was obtained. Fit indices obtained in the confirmatory factor analysis were as follows: χ2 = 181.116, df = 116 χ2/df value 1.561, Root Mean Square Error of Approximation (RMSEA) = 0.058, Comparative Fit Index (CFI): 0.88 and Goodness Fit Index (GFI): 0.88. Item-total scale correlation coefficients were found to range between 0.57 and 0.25. The Cronbach's alpha reliability coefficient was 0.74 for the overall scale and 0.63, 0.77 and 0.65 for its subscales. Conclusions: ATAS was found to be a valid and reliable measurement tool in Turkish population. The scale can be used by healthcare professionals to evaluate patients' use of warfarin in a standard way.

Keywords

• warfarin
• adherence
• scale
• validity
• reliability

References

1. References 1. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. J Am Coll Cardiol. 2017;70(2):252-289. doi:10.1016/j.jacc.2017.03.011
2. 2. Cavallari I, Patti G. Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation. Anatol J Cardiol. 2018;19(1):67-71. doi:10.14744/AnatolJCardiol.2017.8256
3. 3. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 SUPPL. 6):160S-198S. doi:10.1378/chest.08-0670
4. 4. Violi F, Lip GYH, Pignatelli P, Pastori D. Interaction between dietary Vitamin K intake and anticoagulation by Vitamin K antagonists: is it really true?: A systematic review. Med (United States). 2016;95(10):1-7. doi:10.1097/MD.0000000000002895 5. Saksena D, Muralidharan S, Mishra YK, et al. Anticoagulation management in patients with valve replacement. J Assoc Physicians India. 2018;66(January):59-74.
5. 6. Kankaya EA, Bilik Ö. Anticoagulant treatment compliance after heart valve prosthesis. Turk J Cardiovasc Nurs. 2018;9(18):29-34. doi:10.5543/khd.2018.19870
6. 7. Morisky DE, Ang A, Krousel-Wood M. Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertens. 2008;10(5):348-354.
7. 8. Al-Qazaz HK, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE. The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90(2):216-221. doi:10.1016/j.diabres.2010.08.012
8. 9. Lam WY, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015;2015. doi:10.1155/2015/217047 10. Naderiravesh N, Bahadoram S, Shiri H, Anbohi SZ, Khodakarim S. Examining the correlation of adherence to warfarin therapy with demographic characteristic. 2015;8(2):103-108.

9. 11. Lee GKY, Wang HHX, Liu KQL, Cheung Y, Morisky DE, Wong MCS. Determinants of Medication Adherence to Antihypertensive Medications among a Chinese Population Using Morisky Medication Adherence Scale. PLoS One. 2013;8(4). doi:10.1371/journal.pone.0062775
10. 12. Mayet AY. Patient adherence to warfarin therapy and its impact on anticoagulation control. Saudi Pharm J. 2016;24:29-34 doi:10.1016/j.jsps.2015.02.005
11. 13. Keeling DM, Baglin T, Tait C, et al. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol. 2011;154(3):311-324. doi:10.1111/j.1365-2141.2011.08753.x
12. 14. Kılıç S, Çelik A, Çakmak HA, et al. The time in therapeutic range and bleeding complications of warfarin in different geographic regions of Turkey: A subgroup analysis of WARFARIN-TR study. Balkan Med J. 2017;34(4):349-355. doi:10.4274/balkanmedj.2016.1617
13. 15. Celik A, Izci S, Kobat MA, et al. The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: warfarin -tr. Anatol J Cardiol. 2015;16:595-600. doi:10.5152/AnatolJCardiol.2015.6474
14. 16. Kilic S, Saracoglu E, Cekici Y, Kilic DD, Yildirim A, Kuzu Z. Effects of Regular Follow-up on Quality of Life and Warfarin Efficiency in Rural Patients. Eur J Ther. 2019;25(3):183-188. doi:10.5152/eurjther.2018.602
15. 17. Ozkaramanli Gur D, Baykız D, Akyuz A, Alpsoy S, Fidan C. The Influence of Warfarin Adherence on Time in Therapeutic Range Among Patients with Mechanical Heart Valves. J Heart Valve Dis. 2018;27(1):55-64. 18. Tülek Z, Dünya CP, Çiftçioğlu RR, Dereci H. Determination of factors that impact adherence to warfarin in patients with stroke. Turk Noroloji Derg. 2019;25(3):146-152. doi:10.4274/tnd.galenos.2019.08068
16. 19. Dogu O, Cinar N, Erkorkmaz U. Development of an oral anticoagulant-use attitude scale, and assessment of its validity and reliability. Saudi Med J. 2018;39(12):1242-1248. doi:10.15537/smj.2018.12.23138
17. 20. Ozdamar K. Scale and test development structural equation modeling. 1st Ed. Istanbul, Nisan Bookstore; 2016 21. Çam MO, Baysan-Arabacı L. Qualitative and Quantitative Steps on Attitude Scale Construction. Turkish Journal of Research & Development in Nursing. 2010; 12(2):59-71
18. 22. Şencan H. Validity and Reliability in Social and Behavioral Measurements. 1st ed. Ankara, Seçkin Publishing; 2005
19. 23. Kankaya EA, Bilik Ö. The Invisible Face Of The Iceberg: Experience With The Use Of Warfarin In Patients With Heart Valve Surgery: A Qualitative Research.. 14th Internatioanl Congress of Update in Cardiology qnd Cardiovascular Surgery:Abstract Book. The journal of cardiovascular surgery. 2019;53(1-3):60-61
20. 24. Beavers AS, Lounsbury JW, Richards JK, Huck SW, Skolits GJ, Esquivel SL. Practical Considerations for Using Exploratory Factor Analysis in Educational Research. Pract Assessment, Res Eval. 2013;18(6).
21. 25. Seçer, İ. Psychological test development and adaptation process: SPSS and LISREL applications. 2nd ed. Ankara, Anı publishing; 2018
22. 26. Buyukozturk S. Factor analysis: Basic concepts and using to development scale. Educational Administration Theory and Practice. 2002;32(32):470-483
23. 27. Di Minno A, Frigerio B, Spadarella G, et al. Old and new oral anticoagulants: Food, herbal medicines and drug interactions. Blood Rev. 2017;31(4):193-203. doi:10.1016/j.blre.2017.02.001
24. 28. Grant JS, Davis LL. Focus on Quantitative Methods: Selection and Use of Content Experts for Instrument Development. Res Nurs Heal. 1997;20(3):269-274. doi:10.1002/(sici)1098- 240x(199706)20:33.3.co;2-3
25. 29. Streiner DL, Norman GR, Cairney J. Health Measurement Scales: A practical guide to their development and use. 5 ed. ed. Oxford, UK: Oxford University Press; 2014.
26. 30. Tabachnick BG, Fidell LS. Using Multivariate Statistics. Pearson Education. 6th ed. Boston, MA ;2013
27. 31. Karakoç FY, Dönmez L. Basic principles of scale development. Medical Education World. 2014;13(40):39-49. doi:10.25282/ted.228738
28. 32. Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer. Front Public Heal. 2018;6:1-18. doi:10.3389/fpubh.2018.00149
29. 33. Hacihasanoğlu R, Gözüm S, Capik C. Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients [published correction appears in Anadolu Kardiyol Derg. 2012 Nov;12(7):619]. Anadolu Kardiyol Derg. 2012;12(3):241-248. doi:10.5152/akd.2012.068